Yaben Chemical Pharmaceutical Intermediates Project Delayed Completion

Sinochem New Network News Yaben Chemical (300261) announced today that the company's investment project with an annual output of 217 tons of pharmaceutical intermediates construction project involves the import of precision instruments, and the cycle is long, which affects the completion of the project. The company is currently completing the project. Final accounts, preparation of relevant acceptance procedures, is expected to be postponed to April 30 to complete the final accounts.

Yaben Chemical said that the production line has entered the commissioning stage, some projects have started trial production, and some products have been produced, and the production capacity is in the process of gradual release. Therefore, the extension does not have a material impact on the company's operations.